Yuki Gosei Kogyo Co., Ltd. Reports Non-Consolidated Earnings Results for the Three Months Ended June 30, 2017; Provides Earnings Guidance for the First Half of 2018 and Full Year Ending March 31, 2018
August 02, 2017 at 02:30 am EDT
Share
Yuki Gosei Kogyo Co., Ltd. reported non-consolidated earnings results for the three months ended June 30, 2017. For the quarter, the company reported net sales of ¥2,504 million against ¥2,377 million a year ago. Operating income was ¥44 million against operating loss of ¥28 million a year ago. Ordinary income was ¥72 million against ordinary loss of ¥21 million a year ago. Net income was ¥27 million or ¥1.26 per share against ¥1 million or ¥0.08 per share a year ago.
For the first six months of 2018, the company expects net sales of ¥5,300 million, operating income of ¥100 million, ordinary income of ¥90 million and net income of ¥60 million or ¥2.74 per share.
For the year ending March 31, 2018, the company expects net sales of ¥10,700 million, operating income of ¥250 million, ordinary income of ¥230 million and net income of ¥160 million or ¥7.32 per share.
Yuki Gosei Kogyo Co., Ltd. is a Japan-based company mainly engaged in the manufacture and sale of amino acids, chemicals and pharmaceuticals. The amino acids business is involved in the manufacture and sale of amino acids and vitamin ingredients. The chemical products business in involved in the manufacture and sale of the tire cord adhesive raw materials, agricultural chemical intermediates, silicon compounds and other products. The pharmaceuticals business is involved in the manufacture and sale of the pharmaceutical raw materials and intermediates. The commission of manufacture operation business is involved in the contract for manufacture operations through subsidiaries. The Company is also involved in the manufacture and sale of foods, food additives, feed additives, fragrances, and cosmetics, as well as the sale of the related raw materials and products.
Yuki Gosei Kogyo Co., Ltd. Reports Non-Consolidated Earnings Results for the Three Months Ended June 30, 2017; Provides Earnings Guidance for the First Half of 2018 and Full Year Ending March 31, 2018